Company Filing History:
Years Active: 2021
Title: Violeta Sanchez De Delgado: Innovator in Cancer Immunotherapy
Introduction: Violeta Sanchez De Delgado is a prominent inventor based in Nashville, TN, who has made significant contributions to the field of cancer treatment. Her innovative work focuses on methods and systems for predicting responses to immunotherapies, which are crucial for advancing cancer care.
Latest Patents: Violeta holds a patent for "Methods and systems for predicting response to immunotherapies for treatment of cancer." This patent describes a method for detecting cell membrane expression of an MHC molecule in a subject. It also outlines a method for treating cancer using an immunotherapeutic agent. The process involves obtaining a tumor cell sample from a subject and detecting the expression of the MHC molecule by using an antibody that targets it. If the level of expression exceeds a predetermined standard, a therapeutically effective amount of the immunotherapeutic agent is administered.
Career Highlights: Violeta is affiliated with Vanderbilt University, where she continues her research and development in cancer immunotherapy. Her work is instrumental in enhancing the effectiveness of cancer treatments through innovative methodologies.
Collaborations: Violeta collaborates with esteemed colleagues such as Justin M Balko and Douglas B Johnson, contributing to a dynamic research environment focused on improving cancer therapies.
Conclusion: Violeta Sanchez De Delgado exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. Her contributions through her patent and collaborative efforts are paving the way for more effective immunotherapy solutions.